{"id":4026,"date":"2025-05-22T23:03:40","date_gmt":"2025-05-22T23:03:40","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/05\/22\/readout-loud-podcast-gene-editing-crispr-biotech-novo-nordisk-fda\/"},"modified":"2025-05-22T23:03:40","modified_gmt":"2025-05-22T23:03:40","slug":"readout-loud-podcast-gene-editing-crispr-biotech-novo-nordisk-fda","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/05\/22\/readout-loud-podcast-gene-editing-crispr-biotech-novo-nordisk-fda\/","title":{"rendered":"Uncertainty in CRISPR world and the start of more M&amp;A"},"content":{"rendered":"\n<div>Uncertainty in CRISPR world and the start of more M&#038;A<\/div>\n<p> \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>What was the mood like at a big gene therapy conference last week? Why is Novo Nordisk\u2019s CEO stepping down? And why has Adam been in such a good mood?<\/p>\n<p>We discuss all that and more on this week\u2019s episode of \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We chat about M&amp;A deals picking up, leadership changes at Novo, and recent FDA advisory committee meetings for cancer drugs.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/05\/22\/readout-loud-podcast-gene-editing-crispr-biotech-novo-nordisk-fda\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Allison DeAngelis, Elaine Chen, and Adam Feuerstein<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/05\/22\/readout-loud-podcast-gene-editing-crispr-biotech-novo-nordisk-fda\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uncertainty in CRISPR world and the start of more M&#038;A What was the mood like at a big gene therapy conference last week? Why is Novo Nordisk\u2019s CEO stepping down? And why has Adam been in such a good mood? We discuss all that and more on this week\u2019s episode of \u201cThe Readout LOUD,\u201d STAT\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2159,2146,2679,2595,2155,2265],"tags":[2150],"class_list":["post-4026","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-cancer","category-fda","category-gene-editing","category-novo-nordisk","category-pharmaceuticals","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4026"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4026"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4026\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}